Mechanisms and the Evidence Hierarchy

Evidence-based medicine (EBM) makes use of explicit procedures for grading evidence for causal claims. Normally, these procedures categorise evidence of correlation produced by statistical trials as better evidence for a causal claim than evidence of mechanisms produced by other methods. We argue, in contrast, that evidence of mechanisms needs to be viewed as complementary to, rather than inferior to, evidence of correlation. In this paper we first set out the case for treating evidence of mechanisms alongside evidence of correlation in explicit protocols for evaluating evidence. Next we provide case studies which exemplify the ways in which evidence of mechanisms complements evidence of correlation in practice. Finally, we put forward some general considerations as to how the two sorts of evidence can be more closely integrated by EBM.

[1]  A. Rosoff THE GOLD STANDARD: THE CHALLENGE OF EVIDENCE-BASED MEDICINE AND STANDARDIZATION IN HEALTH CARE , 2004 .

[2]  D. Sackett,et al.  Evidence based medicine: what it is and what it isn't , 1996, BMJ.

[3]  Phyllis Illari,et al.  Mechanistic Evidence: Disambiguating the Russo–Williamson Thesis , 2011 .

[4]  David Papineau,et al.  The Virtues of Randomization , 1994, The British Journal for the Philosophy of Science.

[5]  Paul Evans,et al.  A Tale of Two Effects , 2008, The Review of Economics and Statistics.

[6]  J. Worrall Evidence: philosophy of science meets medicine. , 2010, Journal of evaluation in clinical practice.

[7]  B. Clarke Causation and melanoma classification , 2011, Theoretical medicine and bioethics.

[8]  B. Clarke Causality in medicine with particular reference to the viral causation of cancers , 2011 .

[9]  Jacob Stegenga,et al.  Is meta-analysis the platinum standard of evidence? , 2011, Studies in history and philosophy of biological and biomedical sciences.

[10]  Elliott Sober,et al.  The Principle of the Common Cause , 1988 .

[11]  D. Lorenzetti,et al.  Out of context? Translating evidence from the North Karelia project over place and time. , 2006, Health education research.

[12]  Jon Williamson,et al.  What is a mechanism? Thinking about mechanisms across the sciences , 2012 .

[13]  D. Mitchison,et al.  Studies on the treatment of tuberculosis undertaken by the British Medical Research Council Tuberculosis Units, 1946-1986, with relevant subsequent publications. , 1999, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[14]  J. Howick Exposing the Vanities—and a Qualified Defense—of Mechanistic Reasoning in Health Care Decision Making , 2011, Philosophy of Science.

[15]  Jon Williamson,et al.  Generic versus single-case causality: the case of autopsy , 2011 .

[16]  P. Machamer,et al.  Thinking about Mechanisms , 2000, Philosophy of Science.

[17]  Markus Abt,et al.  Effects of dalcetrapib in patients with a recent acute coronary syndrome. , 2012, The New England journal of medicine.

[18]  S. Burger An Introduction to the Study of Experimental Medicine , 1950, The Pharos of Alpha Omega Alpha-Honor Medical Society. Alpha Omega Alpha.

[19]  A. L. Caze,et al.  The role of basic science in evidence-based medicine , 2011 .

[20]  D. Steel Across Boundaries , 2007 .

[21]  E. Wagner The North Karelia Project: what it tells us about the prevention of cardiovascular disease. , 1982, American journal of public health.

[22]  Sander Greenland,et al.  Modern Epidemiology 3rd edition , 1986 .

[23]  Jennifer G. Robinson,et al.  Safety and tolerability of dalcetrapib (RO4607381/JTT-705): results from a 48-week trial , 2010, European heart journal.

[24]  William P Coleman Design and analysis issues. , 2009, Frontiers of neurology and neuroscience.

[25]  Hans Reichenbach Book Reviews: The Theory of Probability: An Inquiry into the Logical and Mathematical Foundations of the Calculus of Probability , 1950 .

[26]  Econometric Policy Evaluation , 2022 .

[27]  D. Bem Feeling the future: experimental evidence for anomalous retroactive influences on cognition and affect. , 2011, Journal of personality and social psychology.

[28]  Wesley C. Salmon,et al.  Statistical explanation & statistical relevance , 1971 .

[29]  David L. Sackett,et al.  Evidence based medicine: What it is and what it isn't (reprinted from BMJ, vol 312, pg 71-72, 1996) , 2007 .

[30]  Jon Williamson,et al.  Inferring causation in epidemiology : mechanisms , black boxes , and contrasts , 2010 .

[31]  A. B. Hill The Environment and Disease: Association or Causation? , 1965, Proceedings of the Royal Society of Medicine.

[32]  R. Hyman Quasi-Experimentation: Design and Analysis Issues for Field Settings (Book) , 1982 .

[33]  How necessary are randomized controlled trials , 2012 .

[34]  Jon Williamson,et al.  Bayesian Nets and Causality: Philosophical and Computational Foundations , 2005 .

[35]  G. Guyatt,et al.  Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis. , 2010, JAMA.

[36]  A. B. Hill,et al.  "The Environment and Disease: Association or Causation?" (1965), by Austin Bradford Hill , 2017 .

[37]  A. B. Hill,et al.  Chemotherapy of pulmonary tuberculosis in young adults; an analysis of the combined results of three Medical Research Council trials. , 1952, British medical journal.

[38]  Jean Gayton Carroll,et al.  The Gold Standard: The Challenge of Evidence-Based Medicine and Standardization in Health Care , 2004 .

[39]  A. Caze Evidence‐Based Medicine Can’t Be… , 2008 .

[40]  Nancy Cartwright What are randomised controlled trials good for? , 2009 .

[41]  Stefan Dragulinescu On ‘Stabilising’ medical mechanisms, truth-makers and epistemic causality: a critique to Williamson and Russo’s approach , 2011, Synthese.

[42]  François Claveau,et al.  The Russo-Williamson Theses in the social sciences: causal inference drawing on two types of evidence. , 2012, Studies in history and philosophy of biological and biomedical sciences.

[43]  K. C. Carter The Decline of Therapeutic Bloodletting and the Collapse of Traditional Medicine , 2012 .

[44]  Ahmed Tawakol,et al.  Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial , 2011, The Lancet.

[45]  John Worrall,et al.  Why There's No Cause to Randomize , 2007, The British Journal for the Philosophy of Science.

[46]  L. Leibovici,et al.  Effects of remote, retroactive intercessory prayer on outcomes in patients with bloodstream infection: randomised controlled trial , 2001, BMJ : British Medical Journal.

[47]  Thomas D. Brock,et al.  Robert Koch - A Life in Medicine and Bacteriology , 1988 .

[48]  I. J. Bross The Theory of Probability. An Inquiry Into the Logical and Mathematical Foundations of the Calculus of Probability.Hans Reichenbach , Ernest H. Hutten , Maria Reichenbach , 1951 .

[49]  Donald W. Gillies The Russo–Williamson thesis and the question of whether smoking causes heart disease , 2011 .

[50]  Jon Williamson,et al.  Interpreting Causality in the Health Sciences , 2007 .

[51]  M. Worboys Robert Koch: a life in medicine and bacteriology , 1990, Medical History.

[52]  Eileen Munro,et al.  The limitations of randomized controlled trials in predicting effectiveness. , 2010, Journal of evaluation in clinical practice.

[53]  James H. Fetzer Statistical Explanation and Statistical Relevance , 1981 .

[54]  Timothy L. Lash,et al.  Comprar Modern Epidemiology | Timothy L. Lash | 9781451190052 | Lippincott Williams & Wilkins , 2012 .

[55]  W. Bechtel Mental Mechanisms: Philosophical Perspectives on Cognitive Neuroscience , 2007 .

[56]  Jon Williamson How Can Causal Explanations Explain? , 2013 .

[57]  What does randomisation achieve? , 2011, Evidence Based Medicine.

[58]  J. Boissel,et al.  Evidence of clinical efficacy of homeopathy , 2000, European Journal of Clinical Pharmacology.

[59]  J. Boissel,et al.  Evidence of clinical efficacy of homeopathy. A meta-analysis of clinical trials. HMRAG. Homeopathic Medicines Research Advisory Group. , 2000, European journal of clinical pharmacology.

[60]  P. Hedström,et al.  Social Mechanisms: An Analytical Approach to Social Theory. , 1999 .

[61]  John Worrall,et al.  What Evidence in Evidence‐Based Medicine? , 2002, Philosophy of Science.

[62]  P. Demeulenaere Analytical Sociology and Social Mechanisms , 2011 .

[63]  E. Bickerstaff Explaining the Brain , 1976 .

[64]  A. Hill,et al.  Suspended judgment. Memories of the British Streptomycin Trial in Tuberculosis. The first randomized clinical trial. , 1990, Controlled clinical trials.

[65]  N. D’Esopo,et al.  STREPTOMYCIN TREATMENT OF PULMONARY TUBERCULOSIS , 1998, The Journal of clinical investigation.

[66]  J. Dupré Across the Boundaries: Extrapolation in Biology and Social Science , 2010 .

[67]  Keith T Palmer,et al.  IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 98: Painting, Firefighting and Shiftwork. International Agency for Research on Cancer , 2011 .

[68]  E. Weber How Probabilistic Causation Can Account for the Use of Mechanistic Evidence , 2009 .

[69]  Jon Williamson,et al.  Imaging Technology and the Philosophy of Causality , 2011 .

[70]  M. Solomon Just a paradigm: evidence-based medicine in epistemological context , 2011 .

[71]  Heejung Bang,et al.  Blood pressure usually considered normal is associated with an elevated risk of cardiovascular disease. , 2006, The American journal of medicine.

[72]  Raffaella Campaner Understanding mechanisms in the health sciences , 2011, Theoretical medicine and bioethics.

[73]  Nancy Cartwright,et al.  Evidence-Based Policy: A Practical Guide to Doing It Better , 2012 .

[74]  Jon Williamson,et al.  Epistemic causality and evidence-based medicine. , 2011, History and philosophy of the life sciences.

[75]  Jon Williamson,et al.  Causality in the Sciences , 2011 .

[76]  S. Lewin,et al.  Patient Adherence to Tuberculosis Treatment: A Systematic Review of Qualitative Research , 2007, PLoS medicine.

[77]  László E. Szabó,et al.  The Principle of the Common Cause , 2013 .

[78]  K. Bock [The evidence (in) the evidence-based medicine]. , 2001, Medizinische Klinik.

[79]  W. Salmon Objectively homogeneous reference classes , 1977, Synthese.

[80]  A. L. Caze Evidence-based medicine must be ... , 2009 .

[81]  Jon Williamson,et al.  The evidence that evidence-based medicine omits. , 2013, Preventive medicine.

[82]  G. Bell Selection: The Mechanism of Evolution , 2008 .

[83]  Christopher J. Portier,et al.  IARC MONOGRAPHS ON THE EVALUATION OF CARCINOGENIC RISKS TO HUMANS PReAMBLe , 2011 .

[84]  Jon Williamson,et al.  EnviroGenomarkers: The Interplay Between Mechanisms and Difference Making in Establishing Causal Claims , 2012 .

[85]  A. Dhar,et al.  National Institute for Health and Clinical Excellence , 2005 .

[86]  E. Vartiainen,et al.  The North Karelia Project: From North Karelia to national action: venäjänkielinen laitos , 2009 .

[87]  Raffaella Campaner,et al.  Evidence and the Assessment of Causal Relations in the Health Sciences , 2012 .

[88]  Donald C. Williams,et al.  The Theory of Probability: An Inquiry into the Logical and Mathematical Foundations of the Calculus of Probability. , 1950 .

[89]  T. Cook,et al.  Quasi-experimentation: Design & analysis issues for field settings , 1979 .

[90]  J. Bryce,et al.  Evidence-based public health: moving beyond randomized trials. , 2004, American journal of public health.

[91]  M. Daniels Streptomycin treatment of pulmonary tuberculosis. , 1949, Medical times.

[92]  Michael Worboys,et al.  Louis Pasteur , 2001, Nature.

[93]  L. Darden Reasoning In Biological Discoveries , 2006 .